Pneumokinetic therapy with glucocorticoids and 5 FU in the treatment of hypertrophic scars

Author:

Nogerov A. R.ORCID, ,Kruglova L. S.ORCID,Stenko A. G.ORCID, ,

Abstract

Corticosteroid injections, ointments, and patches are quite effective for hypertrophic scars. In addition to their direct anti-inflammatory effects, steroids also act by causing vasoconstriction. Current evidence suggests that 5‑FU is an alternative to glucocorticoids for the treatment of hypertrophic scars. According to research, 5‑FU can significantly improve the appearance of pathological scars and reduce the likelihood of relapse. Recently published studies have shown the effectiveness of laser therapies, including pulsed dye laser, fractional CO2‑laser, copper bromide laser, and UVA1 phototherapy. Purpose: to evaluate the effectiveness of pneumokinetic administration of drugs. Material and methods. The study group included 34 patients with hypertrophic scars who underwent 2 procedures of pneumokinetic therapy with glucocorticoids and 5‑FU, with an interval of 2 months. After another 1 month, laser therapy was performed with a neodymium laser (1064 nm). Efficiency control was carried out using DUB SkinScanner, a device for ultrasound examination and determination of morphofunctional parameters of the skin. Results. The study group showed pronounced positive dynamics. The thickness of the epidermis increased by 25.4 %; echodensity decreased by 17.8 %. The thickness of the dermis and its echodensity are more indicative; in relation to these parameters, the following dynamics were noted: a decrease in the thickness of the dermis by 48.0 % and an increase in echoicity by 46.6 %. Ultrasound data revealed a higher efficiency of the combined use of pneumokinetic therapy with glucocorticoids and 5‑FU with sequential laser therapy (neodymium laser at 1064 nm). Conclusion: The combined use of pneumokinetic therapy with glucocorticoids and 5‑FU with sequential laser therapy (neodymium laser at 1064 nm) is a highly effective method of treating hypertrophic scars and can be recommended for use in practical healthcare.

Publisher

PANORAMA Publishing House

Subject

General Medicine

Reference8 articles.

1. 1. Hu H, Mao G, Zheng J, Guo F. Keloid Patient Plasma-Derived Exosomal hsa_circ_0020792 Promotes Normal Skin Fibroblasts Proliferation, Migration, and Fibrogenesis via Modulating miR-193a-5p and Activating TGF-β1/Smad2/3 Signaling. Drug Des Devel Ther. 2022 Dec 8; 16: 4223-4234.

2. Differential and exclusive diagnosis of diseases that resemble keloids and hypertrophic scars;Ogawa;Ann Plast Surg,2009

3. 3. Ikonnikova E.V., Kruglova L. S., Manturova N. E., Petrii M.A. Sravnitelnoe issledovanie effektivnosti i bezopasnosti iniektsionnoi kombinirovannoi terapii keloidnykh i gipertroficheskikh rubtsov 5-ftoruratsilom i betametazonom [A comparative study of the effectiveness and safety of injection combination therapy for keloid and hypertrophic scars with 5-fluorouracil and betamethasone]. Rossiiskii zhurnal kozhnykh i venericheskikh boleznei [Russian Journal of Skin and Venereal Diseases]. 2020; 23 (6): 432-442. (In Russ.)

4. 4. Ismailian K.V., Nagornev S.N., Kruglova L. S., Frolkov V. K. Organizatsiia mikrotsirkuliatornogo rusla nezrelykh gipertroficheskikh rubtsov kozhi i patogeneticheskoe obosnovanie kompleksnogo primeneniia impulsnogo lazera na krasitele i fonoforeza kollagenaz v korrektsii parametrov mikrotsirkuliatorno-tkanevykh sistem [Organization of the microvasculature of immature hypertrophic skin scars and pathogenetic rationale for the complex use of a pulsed dye laser and phonophoresis of collagenases in the correction of parameters of microcirculatory tissue systems]. Effektivnaia farmakoterapiia [Effective Pharmacotherapy]. 2022; 18 (31): 22-27. (In Russ.)

5. Pilot study of the efficacy of 578 nm copper bromide laser combined with intralesional corticosteroid injection for treatment of keloids and hypertrophic scars;Son;Ann Dermatol,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3